Renovacor Announces the Appointment of Jiwen Zhang, Ph.D., as Senior Vice President, Regulatory…
PHILADELPHIA, July 12, 2021 (GLOBE NEWSWIRE) -- Renovacor, Inc. (“Renovacor”), an early‑stage biotechnology company developing adeno-associated virus (AAV)‑based gene therapies for devastating cardiovascular and central nervous system…